SELLAS Life Sciences Group Inc. Common Stock vs SpaceX — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.68 (market cap $2.27B), while SpaceX trades at $164.43 (market cap $2.18T). The key difference: SpaceX is far larger — about 960.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| SLS | SPCX | |
|---|---|---|
Market Cap | $2.27B | $2.18T |
Volume | 4,179,659 | 68,508,567 |
Sector | Health | Industrials |
52-Week High | $15.46 | $202.09 |
52-Week Low | $1.39 | $108.27 |
Enterprise Value | $2.14B | $2.12T |
Typical Hold Time | — | 41 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →